Have a personal or library account? Click to login
Investigation of the structural requirement for inhibiting HIV integrase: QSAR study Cover

Investigation of the structural requirement for inhibiting HIV integrase: QSAR study

By: Nigus Dessalew  
Open Access
|Mar 2009

References

  1. D. Finzi, J. Blankson, J. D. Siliciano, J. B. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. C. Quinn, R. E. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant and R. F. Siliciano, Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, Nat. Med. 5 (1999) 512-517; DOI: 10.1038/8394.10.1038/8394
  2. S. G. Deeks, M. Smith, M. Holodniy and J. O. Kahn, HIV-1 protease inhibitors. A review for clinicians, JAMA 277 (1997) 145-153; DOI: 10.1001/jama.277.2.145.10.1001/jama.277.2.145
  3. J. Martinez-Picado, M. P. DePasquale, N. Kartsonis, G. J. Hanna, J. Wong, D. Finzi, E. Rosenberg, H. F. Günthard, L. Sutton, A. Savara, C.J. Petropoulos, N. Hellmann, B. D. Walker, D. Richman, R. Siliciano and R. T. D'Aquila, Antiretroviral resistance during successful therapy of HIV type 1 infection, Proc. Natl. Acad. Sci. USA 97 (2000) 10948-10953.10.1073/pnas.97.20.10948
  4. C. L. Kuiken, B. Foley, B. Hahn, P. A. Marx, F. McCutchan, J. Mellors, J. Mullins, S. Wolinsky and B. Korber, HIV Sequence Compendium 2000, Theoretical Biology and Biophysics Group, Los Alamos National Labatory: Los Alamos, Wiley, New York 2000.
  5. P. O. Brown, Integration, in Retroviruses (Eds. J. M. Coffin, S. H. Hughes and H. E. Varmus), Cold Spring Harbor Laboratry Press, Cold Spring Harbor, New York 1997, pp. 161-203.
  6. E. Asante-Appiah and A. M. Skalka, HIV-1 integrase: structural organization, conformational changes, and catalysis, Adv. Virus Res. 52 (1999) 351-369; DOI: 10.1016/S0065-3527(08)60306-1.10.1016/S0065-3527(08)60306-1
  7. N. J. Anthony, HIV-1 integrase: a target for new AIDS chemotherapeutics, Curr. Top. Med. Chem. 4 (2004) 979-990; DOI: 10.2174/1568026043388448.10.2174/156802604338844815134552
  8. T. K Chiu and D. R. Davies, Structure and function of HIV-1 integrase, Curr. Top. Med. Chem. 4 (2004) 965-977; DOI: 10.2174/1568026043388547.10.2174/156802604338854715134551
  9. A. Kovatcheva, G. Buchbauer, A. Golbraikh and P. Wolschann, QSAR modeling of alpha-campholenic derivatives with sandalwood odor, J. Chem. Inf. Comput. Sci. 43 (2003) 259-266; DOI: 10.1021/ci020296n.10.1021/ci020296n12546561
  10. N. Dessalew and P. V. Bharatam, 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: An insight into the criteria for selectivity, Eur. J. Med. Chem. 42 (2007) 1014-1027; DOI: 10.1016/j.ejmech.2007.01.010.10.1016/j.ejmech.2007.01.01017335939
  11. N. Dessalew, D. S. Patel and P. V Bharatam, 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3b inhibitors, J. Mol. Graph. Mod. 25 (2007) 885-895; DOI: 10.1016/j.jmgm.2006.08.009.10.1016/j.jmgm.2006.08.00917018257
  12. N. Dessalew, P. V. Bharatam and S. K. Singh, 3D-QSAR CoMFA study on aminothiazole derivatives as cyclin-dependent kinase 2 inhibitors, QSAR Comb. Sci. 26 (2007) 85-91; DOI: 10.1002/qsar.200630032.10.1002/qsar.200630032
  13. N. Dessalew, QSAR study on aminophenylbenzamides and acrylamides as histone deacetylase inhibitors: An insight into the structural basis of antiproliferative activity, Med. Chem. Res. 7 (2008), 449-460; DOI: 10.1007/s00044-007-9085-9.10.1007/s00044-007-9085-9
  14. D. C. Meadows, T. B. Mathews, T. W. North, M. J. Hadd, C. L. Kuo, N. Neamati and J. Gervay-Hague, Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors, J. Med. Chem. 48 (2005) 4526-4534; DOI: 10.1021/jm049171v.10.1021/jm049171v15999991
  15. J. A. Grobler, K. Stillmock, B. Hu, M. Witmer, P. Felock, A. S. Espeseth, A. Wolfe, M. Egbertson, M. Bourgeois, J. Melamed, J. S. Wai, S. Young, J. Vacca and D. J. Hazuda, Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes, Proc. Natl. Acad. Sci. USA 99 (2002) 6661-6666; DOI: 10.1073/pnas.092056199.10.1073/pnas.09205619912445911997448
  16. W. G. Verschueren, I. Dierynck, I. E. Katie, L. Hu, M. J. Paul, G. Boonants, M. E. Pille, F. D. Frits, K. Hertogs, L. N. Dominique, G. Surleraux, B. T. Piet and P. Wigerinck, Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 Integrase, J. Med. Chem. 48 (2005) 1930-1940; DOI: 10.1021/jm049559q.10.1021/jm049559q15771437
  17. A. Verloop, W. Hoogenstraaten and J. Tipker, Development and Application of new Steric Substituent Parameters, in Drug Design (Ed. E. J. Ariens), Academic Press, New York 1976, pp. 165-207.10.1016/B978-0-12-060307-7.50010-9
  18. A. Verloop and J. Tipker, Use of linear free energy related and other parameters in the study of fungicidal selectivity, Pest. Sci. 7 (1976) 379-390.10.1002/ps.2780070410
  19. Verloop and J. Tipker, A comparative study of new parameters in drug design, in Biological Activity and Chemical Structure (Ed. J. A. Keverling Buisman), Elsevier, Amsterdam 1977, pp. 63-81.
DOI: https://doi.org/10.2478/v10007-009-0006-y | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 31 - 43
Published on: Mar 20, 2009
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2009 Nigus Dessalew, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 59 (2009): Issue 1 (March 2009)